New: OxyContin’s makers delayed the reckoning for their role in the opioid crisis by funding think tanks, placing friendly experts on leading outlets, and deterring or challenging negative coverage.https://t.co/3NgYySih6R— ProPublica (@propublica) November 19, 2019